New oncological therapies and the "right" price Authors Enrico Bosone Direttore Corporate Affairs and Market Access, Celgene srl, Milano - Italy DOI: https://doi.org/10.33393/grhta.2015.325
Downloads PDF (Italian) How to Cite Bosone, E. (2015). New oncological therapies and the "right" price. Global and Regional Health Technology Assessment, 2(1), 59–60. https://doi.org/10.33393/grhta.2015.325 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 2 No. 1 (2015): January-April 2015 Section Correspondence License Copyright (c) 2015 The authors This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Metrics Statistics Abstract views - 570 times PDF (Italian) downloads - 523 times Sign up Browse Sections Health Technology Assessment Health Policies banners150 0.8 2023CiteScore 28th percentile Powered by Completed peer reviews since:November 4, 2020 Most popular articles in the last 30 days Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections 108 Assessment and value of drugs: report of the focus groups from the XXII National Conference on Pharmaceuticals 105 Management and utilization of the Fund for Innovative Medicines: a multistakeholder qualitative survey on regional and local practices 105 Towards a Green Health Technology Assessment: embedding Life Cycle Assessment for sustainable choices 102 Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy 101